Previous studies have shown that individuals with newly diagnosed systemic lupus erythematosus (SLE) have an increased risk of pulmonary complications. However, these analyses did not consistently account for potential confounding variables. Recent evidence highlights the importance of routine pulmonary screening and emphasizes the need to take a proactive approach to the management of pulmonary problems in this patient group.
Autoren
- Jens Dehn
Publikation
- InFo RHEUMATOLOGIE
- InFo PNEUMOLOGIE & ALLERGOLOGIE
Related Topics
You May Also Like
- Heart failure and type 2 diabetes
Oral semaglutide and cardiac decompensation in type 2 diabetes
- Atopic dermatitis as a door opener for an atopic cascade?
AD trajectories: Summary of current findings
- New evidence on descensus, urinary incontinence and the future of reconstruction
Urogynecology and pelvic floor surgery 2026
- Proteins in wound healing
Do special amino acids lead to success?
- Case study
Autosomal recessive polycystic kidney disease: atypical phenotype
- Current evidence, risk classes and new counseling options
Hormonal contraception and cardiovascular risk
- Acute otitis media: self-limiting course vs. "red flags"
In which cases are antibiotics necessary?
- Prurigo nodularis: evidence-based treatment